4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Celularity Inc. (CELU) operates in the Biotechnology industry and is headquartered in Florham Park, United States with about 115 employees. Its market capitalization is roughly $26 million. In the fiscal year ended 2025-12-31, CELU reported $27M in revenue and ($92M) in net income.
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking.
Interactive charts & full statements → Open the CELU valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $19M | $27M | $54M | $23M | $18M | — |
| Gross Profit | $4M | $6M | $39M | $7M | ($2M) | — |
| Operating Income (EBIT) | ($49M) | ($61M) | ($38M) | ($192M) | ($26M) | — |
| Net Income | ($46M) | ($92M) | ($58M) | ($196M) | $14M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $5M | $4M | $4M | $5M | $6M | — |
| Gross Profit | $3M | $2M | ($3M) | $1M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($10M) | ($22M) | ($13M) | ($16M) | — |
| Net Income | $1M | $1M | ($24M) | ($23M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | ($6M) | $0M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | — | $0M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $107M | $133M | $144M | $401M | — |
| Total Liabilities | $145M | $124M | $103M | $202M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CELU viewer.
About TickerBase · Data methodology & sources · Privacy · Terms